Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

MORGAN STANLEY (MS)

  • SEC News
  • Aug. 13, 2026, 11:32 UTC
  • 0
  • 0 comments

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039758 <b>Size:</b> 393 KB

Comment Full text

BANK OF NOVA SCOTIA (BNS)

  • SEC News
  • Aug. 13, 2026, 11:32 UTC
  • 0
  • 0 comments

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039757 <b>Size:</b> 663 KB

Comment Full text

Karyopharm Therapeutics Inc (KPTI)

  • Business News
  • Aug. 13, 2026, 11:32 UTC
  • 0
  • 1 comments

Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission

Market reaction Comment Full text

FENNEC PHARMACEUTICALS INC. (FENC)

  • SEC News
  • Aug. 13, 2026, 11:32 UTC
  • 0
  • 0 comments

New Form SCHEDULE 13G/A - FENNEC PHARMACEUTICALS INC. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001622627-26-000020 <b>Size:</b> 12 KB

Comment Full text

JPMORGAN CHASE & CO (JPM)

  • SEC News
  • Aug. 13, 2026, 11:30 UTC
  • 0
  • 0 comments

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023655 <b>Size:</b> 717 KB

Comment Full text

Abeona Therapeutics Inc. (ABEO)

  • Business News
  • Aug. 13, 2026, 11:30 UTC
  • 0
  • 1 comments

Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update

Market reaction Comment Full text

Cabaletta Bio Inc (CABA)

  • Business News
  • Aug. 13, 2026, 11:30 UTC
  • 0
  • 1 comments

Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update

Market reaction Comment Full text

NERVGEN PHARMA CORP. (NGEN)

  • Business News
  • Aug. 13, 2026, 11:30 UTC
  • 0
  • 1 comments

NervGen Reports Second Quarter 2026 Financial Results and Provides Business Updates

Market reaction Comment Full text

RIO TINTO PLC (RIO)

  • Business News
  • Aug. 13, 2026, 11:30 UTC
  • 0
  • 1 comments

Rio2 Reports Q2 2026 Financial and Operating Results and Webinar

Market reaction Comment Full text

REBORN COFFEE, INC. (REBN)

  • Business News
  • Aug. 13, 2026, 11:30 UTC
  • 0
  • 1 comments

Reborn Coffee Signs $20 Million Annual Supply Agreement with The Mighty Oak, Strengthening Its Revenue Base and Profitability Through the Conversion of Existing Supply Volume

Market reaction Comment Full text

COLLEGIUM PHARMACEUTICAL, INC (COLL)

  • Business News
  • Aug. 13, 2026, 11:30 UTC
  • 0
  • 1 comments

Collegium Announces $50 Million Accelerated Share Repurchase Program

Market reaction Comment Full text

BTQ TECHNOLOGIES CORP. (BTQ)

  • Business News
  • Aug. 13, 2026, 11:30 UTC
  • 0
  • 1 comments

BTQ Technologies Signs MOU with ITCENGLOBAL, a KRW 8.9 Trillion Korean IT Group, to Advance Post-Quantum Security Across Koreas Financial, Public-Sector, and Enterprise Infrastructure

Market reaction Comment Full text

CABALETTA BIO, INC. (CABA)

  • Business News
  • Aug. 13, 2026, 11:30 UTC
  • 0
  • 1 comments

Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update

Market reaction Comment Full text

KARYOPHARM THERAPEUTICS INC. (KPTI)

  • Business News
  • Aug. 13, 2026, 11:30 UTC
  • 0
  • 1 comments

Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission

Market reaction Comment Full text

BRAGG GAMING GROUP INC. (BRAG)

  • Business News
  • Aug. 13, 2026, 11:30 UTC
  • 0
  • 1 comments

Bragg Gaming Group Reports Second Quarter 2026 Financial Results

Market reaction Comment Full text
  • Previous
  • 346
  • 347
  • 348
  • 349
  • 350
  • Next

Search

News categories

  • Technical Exchange News(14281)
  • Event(6229)
  • SEC News(370799)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(227255)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin